Jeffrey Hackman

This profile gathers the share dealings of Jeffrey Hackman in Novelion Therapeutics Inc. We count 3 filings; the first trade dates from 1 November 2017 and the latest from 1 November 2018.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

Most recently, on 5 November 2018, the filings show a share grant worth €25k in Novelion Therapeutics Inc. The median gap between trade and publication is zero days: most filings appear on the same day. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.